0001562180-20-002044.txt : 20200303
0001562180-20-002044.hdr.sgml : 20200303
20200303180211
ACCESSION NUMBER: 0001562180-20-002044
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200228
FILED AS OF DATE: 20200303
DATE AS OF CHANGE: 20200303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANDO GORAN
CENTRAL INDEX KEY: 0001110748
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51122
FILM NUMBER: 20684403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001314102
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 262774444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-926-5000
MAIL ADDRESS:
STREET 1: 480 PLEASANT STREET
STREET 2: SUITE B300
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida Corp.
DATE OF NAME CHANGE: 20080619
FORMER COMPANY:
FORMER CONFORMED NAME: pSivida LTD
DATE OF NAME CHANGE: 20050111
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-02-28
false
0001314102
EyePoint Pharmaceuticals, Inc.
EYPT
0001110748
ANDO GORAN
C/O EYEPOINT PHARMACEUTICALS, INC.
480 PLEASANT STREET
WATERTOWN
MA
02472
true
false
false
false
Restricted Stock Units
0.00
2020-02-28
4
A
false
21500.00
0.00
A
2021-02-28
Common Stock
21500.00
21500.00
D
Stock Option (Right to Buy)
1.29
2020-02-28
4
A
false
38500.00
0.00
A
2021-02-28
2030-02-28
Common Stock
38500.00
38500.00
D
Will fully vest on the one-year anniversary of the grant date.
/s/ John Mercer, Attorney-in-Fact
2020-03-03